Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Title
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 378, Issue 19, Pages 1789-1801
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2018-04-15
DOI
10.1056/nejmoa1802357

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search